Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ZFP36L1 - Oligooxopiperazine effect on hypoxic alveolar adenocarcinoma cell line
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
ZFP36L1 - Long-term octreotide treatment of neuroendocrine tumor cell line CNDT2.5
ZFP36L1 - Kidney transplant rejection expression profiling
ZFP36L1 - Xenograft ovarian tumor response to anti-cancer therapeutic MT19: time course
ZFP36L1 - Inflammatory cytokine effect on primary dermal endothelial cells
ZFP36L1 - Carboplatin sensitive and resistant ovarian carcinoma
ZFP36L1 - PPARĪ± agonist ciprofibrate effect on liver
ZFP36L1 - Insulin-Producing Cells generated from dedifferentiated pancreatic islet cells expanded in vitro
ZFP36L1 - Dermal papilla-induced epithelial stem cell differentiation
ZFP36L1 - Post-traumatic stress disorder development
ZFP36L1 - Parkin expression in parkin-deficient U87MG glioma cells
ZFP36L1 - DNA damage effect on memory and non-memory cells
ZFP36L1 - Epidermal keratinocyte differentiation in vitro
ZFP36L1 - Estradiol effect on osteosarcoma cells expressing estrogen receptor alpha or beta: time course
ZFP36L1 - Anaplastic thyroid carcinomas: thyroid biopsies
ZFP36L1 - Inflammatory cytokine effect on primary lung endothelial cells
ZFP36L1 - Breast cancer and docetaxel treatment
ZFP36L1 - Small molecule KY02111 effect on induced pluripotent stem cell line IMR90-1: time course
ZFP36L1 - Renal cancer response to rapamycin analog CCI-779 treatment: time course
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on